SE0002973D0 - Method - Google Patents

Method

Info

Publication number
SE0002973D0
SE0002973D0 SE0002973A SE0002973A SE0002973D0 SE 0002973 D0 SE0002973 D0 SE 0002973D0 SE 0002973 A SE0002973 A SE 0002973A SE 0002973 A SE0002973 A SE 0002973A SE 0002973 D0 SE0002973 D0 SE 0002973D0
Authority
SE
Sweden
Prior art keywords
metalloproteinase
modulators
specidic
adamts
disintegrin
Prior art date
Application number
SE0002973A
Other languages
English (en)
Inventor
Peter Brodin
Anders Thelin
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0002973A priority Critical patent/SE0002973D0/sv
Publication of SE0002973D0 publication Critical patent/SE0002973D0/sv
Priority to EP01956689A priority patent/EP1313874A1/en
Priority to JP2002522302A priority patent/JP2004507468A/ja
Priority to AU2001278610A priority patent/AU2001278610A1/en
Priority to GB0301654A priority patent/GB2381000A/en
Priority to US10/362,262 priority patent/US20040014636A1/en
Priority to PCT/GB2001/003650 priority patent/WO2002016632A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
SE0002973A 2000-08-22 2000-08-22 Method SE0002973D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0002973A SE0002973D0 (sv) 2000-08-22 2000-08-22 Method
EP01956689A EP1313874A1 (en) 2000-08-22 2001-08-16 Pharmaceutical compositions comprising a modulator of adamts-1
JP2002522302A JP2004507468A (ja) 2000-08-22 2001-08-16 Ａｄａｍｔｓ−１のモジュレーターを含んでなる薬剤組成物
AU2001278610A AU2001278610A1 (en) 2000-08-22 2001-08-16 Pharmaceutical compositions comprising a modulator of adamts-1
GB0301654A GB2381000A (en) 2000-08-22 2001-08-16 Pharmaceutical compositions comprising a modulator of adamts-1
US10/362,262 US20040014636A1 (en) 2000-08-22 2001-08-16 Pharmaceutical compositions comprising a modulator of adamts-1
PCT/GB2001/003650 WO2002016632A1 (en) 2000-08-22 2001-08-16 Pharmaceutical compositions comprising a modulator of adamts-1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0002973A SE0002973D0 (sv) 2000-08-22 2000-08-22 Method

Publications (1)

Publication Number Publication Date
SE0002973D0 true SE0002973D0 (sv) 2000-08-22

Family

ID=20280755

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0002973A SE0002973D0 (sv) 2000-08-22 2000-08-22 Method

Country Status (7)

Country Link
US (1) US20040014636A1 (sv)
EP (1) EP1313874A1 (sv)
JP (1) JP2004507468A (sv)
AU (1) AU2001278610A1 (sv)
GB (1) GB2381000A (sv)
SE (1) SE0002973D0 (sv)
WO (1) WO2002016632A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009502115A (ja) * 2005-07-27 2009-01-29 オンコセラピー・サイエンス株式会社 小細胞肺癌の診断方法
WO2007147497A2 (en) * 2006-06-17 2007-12-27 Bayer Healthcare Ag Use of a disintegrin-like and metalloproteinase with thrombospondin type 1 motif (adamts1) as a therapeutic or diagnostic target
JP5809205B2 (ja) * 2013-07-16 2015-11-10 国立大学法人 東京大学 骨粗鬆症感受性遺伝子、及び骨粗鬆症罹患リスクの測定方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0874050A3 (en) * 1997-04-24 2002-06-05 Smithkline Beecham Corporation Integrin ligand ITGL-TSP
WO1998055643A1 (fr) * 1997-06-03 1998-12-10 Kureha Chemical Industry Co., Ltd. Proteine adamts-1 humaine, gene codant pour cette proteine, composition pharmaceutique et procede de dosage immunologique de proteine adamts-1 humaine

Also Published As

Publication number Publication date
EP1313874A1 (en) 2003-05-28
GB0301654D0 (en) 2003-02-26
AU2001278610A1 (en) 2002-03-04
JP2004507468A (ja) 2004-03-11
US20040014636A1 (en) 2004-01-22
WO2002016632A1 (en) 2002-02-28
GB2381000A (en) 2003-04-23

Similar Documents

Publication Publication Date Title
ATE543289T1 (de) Konfigurations- und managementsystem für mobile und eingebettete geräte
DE602004022399D1 (de) Datenzugriff beruhend auf benutzer-identität
DE60317916D1 (de) Tamponapplikator mit verbessertem fingergriff und herstellungsverfahren dafür
DE60330701D1 (de) Verfahren und vorrichtung zum übertragen von vertraulichkeitseinschränkungen unterzogenen daten
WO2002041139A3 (en) Resource files for electronic devices
DK1268847T3 (da) Ubiquitin-ligaseassay
ATE259512T1 (de) Tragbares telefon und einschaltverfahren
SG170642A1 (en) Gpr41 and modulators thereof for the treatment of insulin-related disorders
ATE385374T1 (de) Web-anwendungsserver
DE60137346D1 (de) Rechnerverfahren und -system zum ausführen von java-rechnerprogrammen
DE602004032466D1 (de) Durchführung von prüfungen an der betriebsmittelbenutzung von computerprogrammen
WO2006096740A3 (en) An apparatus and method for employing cloning for software development
ID29095A (id) Antagonis mglur5 untuk pengobatan rasa sakit dan kegelisahan
AR047718A1 (es) Metodos y aparato para determinar la integridad de un dispositivo
ATE405083T1 (de) Rechnersystem und datenverarbeitungsverfahren zum gebrauch eines webdienstes
SE0002973D0 (sv) Method
DE60315992D1 (de) Überwachung von zellen
WO2003005168A3 (en) Use of various methods to reconstruct experiences of web site visitors
DE60019117D1 (de) Substituierte benzamide als inhibitoren von rhinovirus 3c protease
WO2005008384A3 (en) Kernel-level method of flagging problems in applications
WO2006137899A3 (en) Nanosensors for detecting analytes and method of detecting analyteshave been developed in which the redox potential of a redox effector in solution is altered thereby causing changes in the carbon nanotube (30) conductance. the analyte may be detected in solution, eliminating the need for immobilizing the analyte on a support.
DE60327406D1 (de) Tragbares Telefon, Verfahren zur Gültigkeits/Ungültigkeitsmeldung von Tastenbetätigungen an einem tragbaren Telefon und Programm für das Verfahren
DK1054671T3 (da) Ny anvendelse til smertebehandling
DE602004025291D1 (de) Behandlung von neurodegenerativen erkrankungen durch verwendung von laptm4b
HK1097673A1 (en) Method and system for detecting malicious wireless applications